|
End-of-day quote
Egyptian Exchange
03/09/2026
|
5-day change | 1st Jan Change | ||
| 295.64 EGP | -0.59% |
|
+1.13% | +36.97% |
| 05-21 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 04-30 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 2.89B 56.71M 48.78M 45.88M 41.91M 78.47M 5.36B 78.75M 542M 210M 2.74B 213M 208M 8.86B | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 3.32B 65.22M 56.1M 52.76M 48.2M 90.25M 6.16B 90.56M 623M 242M 3.16B 245M 240M 10.19B | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
18.09% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| 1 day | -0.59% | ||
| 1 week | +1.13% | ||
| Current month | -1.37% | ||
| 1 month | -4.63% | ||
| 3 months | +40.01% | ||
| 6 months | +99.80% | ||
| Current year | +36.97% |
| 1 week | 291.12 |  | 315 |
| 1 month | 274 | | 389.99 |
| Current year | 140 | | 389.99 |
| 1 year | 140 | | 389.99 |
| 3 years | 28 | | 389.99 |
| 5 years | 20.5 | | 389.99 |
| 10 years | 3.15 | | 389.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | +1.13% | +67.68% | +883.34% | 69.72M | |
| -0.88% | -2.27% | +55.78% | +106.31% | 1,034B | |
| -1.15% | +3.56% | +54.62% | +71.50% | 671B | |
| -1.44% | -0.65% | +21.05% | +73.05% | 460B | |
| +0.14% | -1.92% | +32.47% | +37.60% | 353B | |
| -1.33% | +3.96% | +25.71% | +45.03% | 309B | |
| -1.15% | -0.89% | -1.67% | +12.21% | 255B | |
| -1.55% | +0.05% | +54.04% | +70.32% | 240B | |
| -0.88% | +1.24% | -18.03% | -54.06% | 207B | |
| -0.15% | +1.43% | +33.64% | +96.99% | 188B | |
| Average | -0.70% | +1.27% | +32.53% | +134.23% | 371.68B | |
| Weighted average by Cap. | -0.55% | +1.04% | +37.27% | +66.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 786M 15.44M 13.28M 12.49M 11.41M 21.36M 1.46B 21.44M 148M 57.28M 747M 57.96M 56.7M 2.41B | 1.12B 21.98M 18.9M 17.78M 16.24M 30.41M 2.08B 30.52M 210M 81.54M 1.06B 82.51M 80.72M 3.43B |
| Net income | 103M 2.02M 1.74M 1.63M 1.49M 2.8M 191M 2.81M 19.31M 7.5M 97.78M 7.59M 7.42M 316M | 228M 4.48M 3.85M 3.62M 3.31M 6.2M 423M 6.22M 42.8M 16.62M 217M 16.81M 16.45M 700M |
| Net Debt | 284M 5.59M 4.81M 4.52M 4.13M 7.73M 528M 7.76M 53.41M 20.74M 270M 20.98M 20.53M 873M | 433M 8.51M 7.32M 6.88M 6.29M 11.77M 804M 11.81M 81.31M 31.57M 412M 31.94M 31.25M 1.33B |
Employees
1,148
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | EGP 295.64 | -0.59% | 24,537 |
| 02/09/26 | EGP 297.38 | -2.50% | 18,670 |
| 01/09/26 | EGP 305.01 | +1.76% | 23,846 |
| 31/08/26 | EGP 299.74 | +2.61% | 91,543 |
| 30/08/26 | EGP 292.12 | -0.08% | 14,780 |
- Stock Market
- Stocks
- ADCI Stock
Select your edition
All financial news and data tailored to specific country editions
